SmartLabs Launches Innovative Operational Support Model
SmartLabs, a leading provider of flexible laboratory infrastructure solutions, is redefining the landscape for innovators in the life sciences field with a newly introduced operational support model. This initiative highlights SmartLabs' dedication to improving its services and meeting the varied requirements of the rapidly changing biopharma sector.
Tailored Solutions for Enhanced R&D
This new offering builds on SmartLabs' existing capabilities, combining adaptable lab infrastructure with expert operational support. By skillfully managing laboratory operations and providing unmatched access to specialized knowledge, SmartLabs serves a wider range of stakeholders, including landlords, real estate developers, and academic institutions, helping them optimize their research and development resources.
Partnership with Leaders in Life Sciences
This operational support model is anchored by a collaborative pilot program with a well-regarded leader in life sciences real estate. This partnership highlights the importance and advantages of the model. As Brian Taylor, the CEO of SmartLabs, points out, merging their extensive expertise with a personalized service approach allows scientists to concentrate solely on their research, free from the distractions posed by operational and technical issues.
Comprehensive Support for Research Endeavors
By providing essential engineering, operational, and specialized knowledge, SmartLabs is positioning itself as a supportive ally throughout every stage of research and development. With experience in managing complex operational workflows across a variety of scientific modalities and developmental phases, SmartLabs helps clients direct their resources toward groundbreaking scientific advancements, offering crucial solutions for developing life-saving therapies.
Expanded Offerings for Biotech and Biopharma
The rollout of this new operational support model is a significant progression in SmartLabs' journey. It enables scientists to take advantage of unique laboratory solutions specifically designed for their research demands. By prioritizing operational excellence and scientific accuracy, this expansion represents a major milestone in SmartLabs' mission to enhance access to cutting-edge R&D infrastructure.
About SmartLabs
Founded with a vision to create a robust and adaptable infrastructure for contemporary science, SmartLabs has been a pioneer in delivering integrated solutions since 2015. Their Managed Research Centers provide clients with the opportunity to access private, enterprise-level R&D resources without hefty upfront investments, allowing innovative concepts to thrive at every phase of the drug development process.
Based in Boston, SmartLabs caters to a wide array of biotech, biopharma, and life sciences organizations, using a unique model aimed at supporting the future of the life sciences sector.
Frequently Asked Questions
What is the new operational support model introduced by SmartLabs?
This operational support model enhances SmartLabs' offerings by merging lab infrastructure with comprehensive management services designed to aid life sciences innovators.
Who is SmartLabs collaborating with for the pilot program?
SmartLabs is conducting a pilot program for its new operational support model in partnership with a significant leader in life sciences commercial real estate.
How does SmartLabs assist R&D companies?
SmartLabs delivers end-to-end services that manage laboratory operations while offering access to specialized expertise, allowing R&D companies to maximize their resources effectively.
What systems does SmartLabs use for its solutions?
The solutions stem from SmartLabs' Custom Developed Solutions (CDS) platform, which includes designing and constructing research facilities, as well as managing operational workflows.
What is SmartLabs' goal within the life sciences industry?
SmartLabs aims to ensure the future viability of life sciences infrastructure, expediting scientific discoveries to ultimately enhance patient care and health outcomes.